EMBO Announces 52 New Members for 2013
News May 21, 2013
Forty-three of the researchers reside in Europe and neighboring countries and are accompanied by the election of nine Associate Members from Canada, China, India, Japan and the United States. The EMBO membership currently comprises around 1600 life scientists.
“Our members are the basis for the international reputation of our organisation,” EMBO Director Maria Leptin said. “We have been building our network of members for almost 50 years and the EMBO membership is the foundation for our future growth and achievements. I look forward to the fresh input and ideas that the new EMBO members will bring to the organisation.”
The most recent scientists to join the EMBO membership come from 15 different countries and include 16 female scientists.
EMBO Members make invaluable contributions to the organization by providing suggestions and feedback on the activities of EMBO. They serve on selection committees for EMBO programmes and mentor young scientists. Their input has helped to promote excellence in life sciences since 1964.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE